Mostafa El-Serafi

Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology

Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

Effect of Steatohepatitis Associated with Irinotecan or Oxaliplatin Pretreatment on Resectability of Hepatic Colorectal Metastases

Colorectal cancer

Schistosomiasis

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

Graphene‐Based Materials: Synthesis, Characterization, Properties, and Applications

Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Donor Outcome After Living Liver Donation: A Single-Center Experience

The Clavien-Dindo Classification of Surgical Complications

Bilharziasis of the genitourinary tract

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Reactive Oxygen Species and p53 Mediated Activation of p38 and Caspases is Critically Involved in Kaempferol Induced Apoptosis in Colorectal Cancer Cells

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

Fluoropyrimidine-associated cardiotoxicity: revisited

Ultrasensitive and Selective Detection of a Prognostic Indicator in Early‐Stage Cancer Using Graphene Oxide and Carbon Nanotubes

Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle‐invasive carcinoma of the bladder: Does histologic subtype matter?

OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCOR Study

Kaempferol: A Key Emphasis to Its Anticancer Potential

Radical Cystectomy for Carcinoma of the Bladder: Critical Evaluation of the Results in 1,026 Cases

Donor Outcomes in Right Lobe Adult Living Donor Liver Transplantation: Single-Center Experience in Egypt

Chemotherapy in Invasive Carcinoma of the Bladder A review of phase II trials in Egypt

Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients

Raltitrexed (Tomudex®) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)

Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry

1088 Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: results of EORTC GI group study 40986